Rapid detection of antigen refers to the application of new coronavirus nucleocapsid protein-specific antibodies in the direct detection of pathogens in a sample, the result can be used as direct evidence of early identification of infection the pathogen or not, detecting a rapid (15min), convenient operation of the New coronavirus detection method. Applicable scenarios: Weak nucleic acid detection capabilities, insufficient detection capabilities, and places where urgent results are needed. It has been widely used in Europe, America, Asia, Africa and other regions, and together with nucleic acid testing has become an important detection method for the prevention and control of the COVID-19 epidemic.(Not Available in the U.S)
Real- time PCR is used for sensitive, specific detection and quantification of nucleic acid targets. We have developed powerful assay design algorithms, optimized qPCR regent, intuitive data analysis software, and flexible instrumentation to help harness the power of qPCR across a rich and diverse set of applications. Explore our robust solutions for your qPCR-based research.
2023-05-29
On May 28th, the 20th CACLP was grandly opened at Nanchang Greenland International Expo Center. As a grand event in the IVD industry, it has attracted a large number of domestic and foreign IVD companies and exhibitors to gather here. Read More
2023-05-24
From May 28th to May 30th, 2023, the 20th CACLP will be held in Nanchang. This year, BIOBASE will bring a variety of "star-level" products to the exhibition, and meet you in Nanchang to discuss the innovative development of IVD (In Vitro Diagnosis). Read More